Dr. Yasushi Yatabe, of Aichi Cancer Center in Nagoya, Japan, invites practitioners to complete the 2024 IASLC Biomarker Survey. Your input will shape global policies, research, patient care, and resource development.

Dr. Yasushi Yatabe, from Aichi Cancer Center Hospital in Nagoya, Japan and 2024 Biomarker Testing Survey Steering Committee Member, urges healthcare professionals to participate in the 2024 IASLC Biomarker Survey. Your participation will shape global policies, advance research, improve patient care, and support further resource development. It only takes 10-15 minutes.